NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available for Relief of Moderate to Severe ... ( New Centrally Acting Prescription Med...)

NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available for Relief of Moderate to Severe Acute Pain

Date:6/23/2009

New Centrally Acting Prescription Medicine Treats Pain in Two Ways

RARITAN, N.J., June 23 /PRNewswire/ -- Patients suffering from acute pain and healthcare professionals who treat pain have a new treatment option: NUCYNTA(TM) (tapentadol) CII immediate release tablets. This new medication for the relief of moderate to severe acute pain in patients 18 years of age or older is now available by prescription only in 50-mg, 75-mg and 100-mg tablets, announced PriCara,(R) Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

NUCYNTA(TM) binds to mu-opioid receptors and inhibits norepinephrine re-uptake. Although the exact mechanism of action is not known, these two mechanisms, which affect established pain pathways, are thought to be responsible for pain relief with NUCYNTA.(TM)

More than 25 million Americans experience acute pain each year as a result of injuries or surgery, and acute pain is the most common reason people seek medical attention. Pain is often undertreated, and acute pain in particular may cause serious medical complications, impair recovery from injury or procedures, and may progress to chronic pain if not properly managed.

"In clinical trials, NUCYNTA(TM) provided patients with effective pain relief and was shown to have fewer of the gastrointestinal side effects often reported with prescription pain medications that act on mu-opioid receptors," said Perry Fine, M.D., Professor of Anesthesiology, University of Utah, Salt Lake City, and consultant to PriCara.(R) "This new treatment option offers the potential to improve treatment outcomes for acute pain patients."

On November 20, 2008, the U.S. Food and Drug Administration (FDA) approved NUCYNTA(TM) for the relief of moderate to severe acute pain in patients 18 years of age or older. The U.S. Drug Enforcement Agency has placed NUCYNTA(TM) into Schedule II of the Controlled Substances Act.

'/>"/>

SOURCE PriCara
Copyright©2009 PR Newswire.
All rights reserved

12

GOOD

Page: 1 2 3 4 5 6 7
Related medicine news :

1. Experts Urge Family Members and Friends to Seek Immediate Intervention for Their Loved Ones Who May Have Alzheimers Disease (AD)
2. Pharmacy Technician Certification Board (PTCB) Now Offers Continuous Testing And Immediate Pass/Fail Results
3. BioTech Medical Well-Positioned to Immediately Respond to Swine Flu Emergency with SDC-Based SpectraSan 24 Disinfectant
4. Urgent Care Provider NextCare Opens Two Additional Immediate Care Clinics in Virginia
5. Three New NextCare Immediate Care Clinic Locations Open in Colorado
6. Former House Democratic Leader Richard A. Gephardt to Join MMR Initiative to Promote Immediate Use of Personal Health Records
7. Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
8. Barry Arbuckle, PhD, MemorialCare Medical Centers CEO and Immediate Past Chair, California Hospital Association, Speaks Out on California Budget Passage
9. Immediate Orthopaedic Care Can Help Heal a Young Athletes Shoulder
10. Pharmacy Technician Certification Board (PTCB) Unveils New Testing Features for 2009: PTCB Exam to be Offered Daily; Test Results Given to Candidates Immediately in 2009
11. LCA-Visions Former Executive Management Urge Board of Directors to Immediately Call Special Shareholder Meeting to Approve Poison Pill

Post Your Comments:

(Date:2/9/2010)... is directly related to children,s exposure to commercials that ... of Public Health study published in the American ... by Frederick J. Zimmerman and Janice F. Bell, is ... children watch to better determine whether different kinds of ... researchers gathered data from primary caregivers of 3,563 children, ...

(Date:2/9/2010)... more often in men with fewer complications, study finds ... reveals that women are more likely than men to ... men undergo the procedures five times as often as ... published in the February issue of HeartRhythm Journal ... patients between 2005 and 2008. They underwent pulmonary vein ...

(Date:2/9/2010)... -- Alan Revell of Milford worked for ... quit. What he witnessed was the inspiration for the newly formed ... knew that there had to be a better way to treat ... Care. "What I saw in just one day was enough to ... knew right then that we needed to find a better way ...

(Date:2/9/2010)... Disabled and Children Remains Intact ,, HARRISBURG, Pa. ... With Pennsylvania finances still suffering the effects ... Great Depression, Governor Edward G. Rendell today ... spends $26.3 billion in state money, augmented ... stimulus funds. ,, Requiring no tax increases to balance, ...

(Date:2/9/2010)... Stimulus Resource Library featured on redesigned MxSecure, Inc. site: ... ... (PR WEB) February 9, 2010 -- Medical transcription services ... launch of their new website., , , , ,Improving Medical ... revamped website, and it captures the focus of all the ...

[0] Childhood obesity: It's not the amount of TV, it's the number of junk food commercials [0] Women More Likely to Fail Treatment for Atrial Fibrillation [0] Caring Rose Home Care Launched To Help Seniors Live Independently [0] Governor Rendell Proposes Budget With No Tax Increase, More Money for Public Schools, Strategy for Jobs, Plan to Address Future Deficits [0] Medical Transcription Services and EHR Provider MxSecure Launches New Enhanced Website with Goal of Improved Physician Productivity

... small studies, mepolizumab reduced number of exacerbations, , , WEDNESDAY, March ... therapy might be especially helpful for people with severe asthma ... symptoms. , The drug is called mepolizumab, and two small ... England Journal of Medicine have found that, when taken ...

... Digirad Corporation (Nasdaq: DRAD ), a leading ... leasing services that improve patient care while driving positive ... assets related to its Arizona and Nevada service hub ... Medical Services LLC calls for the sale of portable ...

... Inc. (NYSE: WTW ) today announced its results ... January 3, 2009. Fourth Quarter 2008 Results For ... to $346.2 million, up from $344.0 million in the fourth ... million to revenue, net revenues were down $5.6 million versus ...

... 2009 NORTH HOLLYWOOD, Calif., March 4 IPC The ... leading national hospitalist physician group practice, announced today that ... & Access Method", or "E-Proxy" rules, that allow companies ... as an alternative to the traditional approach of delivering ...

... the first South Florida publication dedicated to providing expert ... sports for men and women, was recognized for ... Awards (FOLIO: Awards for Magazine Events), part of the ... At the morning ceremony, which recognizes the best-of-the-best in ...

... Fame Football Coach and Wife Recognized for Personal Contributions to ... 4 On April 29, 2009 a galaxy ... nonprofits will gather at the Mandarin Oriental Hotel in New ... to helping others in the community and through personal charities, ...

Experimental Drug May Dampen Severe Asthma Digirad Corporation Sells Arizona, Nevada Service Hubs Weight Watchers Announces Fourth Quarter and Full Year 2008 Results IPC The Hospitalist Company Adopts 'E-Proxy' to Reduce Environmental Impact SOBeFiT Magazine Wins Best Magazine Launch Party at 2009 FAME Awards Joe and Sue Paterno to be Honored for Their 'Lifetime of Achievement' at the Honor a Star. Be a Star. Gala at New York's Mandarin Oriental Hotel April 29, 2009

(Date:2/9/2010)... -- Visage Imaging®, Inc., a wholly owned subsidiary of ... Danahy joins as General Manager North America ... the healthcare IT industry, Johns brings a wealth of ... previously VP Sales of Medsphere where he managed the ... the EMR market segment. Prior to joining Medsphere Danahy ...

(Date:2/9/2010)... , February 9 ... of companies with,a focus on the development ... today announced the signature of an exclusive ... and commercialisation of Debio 025,(alisporivir), a selective, ... C virus (HCV) effect. The product is ...

(Date:2/8/2010)... , Feb. 8 Cost reductions ... Products (Nasdaq: AHPI ) narrowly back into profitability ... Sales for the quarter ended December 31, 2009 ... million during the same quarter last year to ... Allied,s costs of sales were reduced even more sharply, ...

Breaking Medicine Technology:Visage Imaging Names John Danahy as General Manager North America, Sales and Services 2 Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 2 Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 3 Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 2 Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 3 Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 4 Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 5 Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions 6 Discovery of a water snake that startles fish in a way that makes them flee into its jaws 8911 1 Discovery of a water snake that startles fish in a way that makes them flee into its jaws 8911 2 Discovery of a water snake that startles fish in a way that makes them flee into its jaws 8911 3 Childrens Hospital Boston CompuCyte Corporation Establish International Quantitative Imaging Cytometry Center 49430 1 Childrens Hospital Boston CompuCyte Corporation Establish International Quantitative Imaging Cytometry Center 49430 2 Childrens Hospital Boston CompuCyte Corporation Establish International Quantitative Imaging Cytometry Center 49430 3 Almost Half of Those Over 60 Die While Waiting for Kidney Transplant 49426 1 Almost Half of Those Over 60 Die While Waiting for Kidney Transplant 49426 2 Almost Half of Those Over 60 Die While Waiting for Kidney Transplant 49426 3

[0] Visage Imaging Names John Danahy as General Manager North America, Sales and Services [0] Debiopharm Group Grants an Exclusive Licence for the Development, Manufacture and Commercialisation of Debio 025 [0] Allied Healthcare Products Returns to Profitability By Offsetting Depressed Sales with Cost Reductions

... FORT WORTH, Texas, July 30 Wound Care ... (OTC Bulletin Board:,WNDM), announced today an evidence based ... performance of their advanced wound care collagen,product, CellerateRx(R), ... the Centers for Disease Control and Prevention, diabetes ...

... Scimitar Equity, LLC issues a review of,Generex Biotechnology ... Oral Drug Delivery Platform, Sets the Tone as ... Global Revenues.", This review is available at ... in the research, development, and commercialization,of drug delivery ...

Other Medicine Technology:Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers 2 Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC 2

Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers Generex Biotechnology Corporation Initiation Coverage Review Issued By Scimitar Equity, LLC

Spring Type with lock. Titanium....

Slitlamp-mounted contact tonometer for precision tonometry (corneal thickness independent)...

... the simplicity and ease of the World's ... and reputation for accuracy, reliability and performance ... rooms. With no wires to limit, ... has full measurement range and advanced measurement ...

... fourth generation septal repair implant. It differs ... a unique self-centering mechanism, fabricated from a ... attached to alternating sides of the umbrella ... mechanism which assists to centrally locate the ...

Medicine Products:

Blade Holder PASCAL Dynamic Contour Tonometer Retinomax K-Plus 2/ Retinomax 2 STARFlex

NUCYNTA(TM) (tapentadol) CII Immediate Release Tablets Now Available for Relief of Moderate to Severe ...( New Centrally Acting Prescription Med...),Health